News for Healthier Living

Decitabine Induces irf7-Mediated Immune Responses in p53-Mutated Triple-Negative Breast Cancer: A Clinical and Translational Study

The findings of this research reveal the potential of repurposing decitabine for the treatment of p53-mutated TNBC and suggest IRF7 as a potential biomarker for decitabine-based treatments.

October 31, 2025


October 31 2025

October 30 2025

October 29 2025

October 28 2025

October 27 2025

October 26 2025

October 25 2025

October 24 2025

October 23 2025

October 22 2025

October 21 2025

October 20 2025

October 19 2025

October 18 2025

October 17 2025